Methods of treating cancer and preventing drug resistance
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- F HOFFMANN LA ROCHE & CO AG
- Publication Date
- 2015-10-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] Provided herein are therapies for the treatment of pathological conditions, such as cancer, using ALDH inhibitors and targeted therapeutics. Background of the invention
[0002] The relatively rapid acquisition of resistance to cancer drugs remains a key obstacle to successful cancer therapy. Significant efforts to elucidate the molecular basis of such drug resistance have revealed multiple mechanisms, including drug efflux, acquisition of drug-binding-deficient mutants of the target, involvement of alternative survival pathways, epigenetic alterations. Such mechanisms are generally thought to reflect the presence of rare, random, resistance-conferring genetic changes within tumor cell populations that are selected during drug treatment (Sharma et al., Cell 141(1):69-80 (2010)). A phenomenon that is increasingly observed in cancer therapy is the so-called "retreatment response". For example, some patients with non-small cell lung cancer (NSCLC) wh...